NEXTECH VI ONCOLOGY SCSP 13D/13G Filings for Tyra Biosciences, Inc. (TYRA)

NEXTECH VI ONCOLOGY SCSP 13D and 13G filings for Tyra Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
5:47 pm
Purchase		 2024-09-30 13G Tyra Biosciences, Inc.
TYRA		 NEXTECH VI ONCOLOGY SCSP 4,055,861
7.700%		 1,537,279increase
(+61.04%)		 Filing
2021-09-27
4:36 pm
Purchase		 2021-09-17 13G Tyra Biosciences, Inc.
TYRA		 NEXTECH VI ONCOLOGY SCSP 2,518,582
5.900%		 2,518,582increase
(New Position)		 Filing